Lyell Immunopharma (LYEL) Accumulated Expenses (2020 - 2026)
Lyell Immunopharma (LYEL) posted Accumulated Expenses of $35.99 million for Q2 2026, up 28.5% from $28 million a year earlier and up 14.3% from the prior quarter.
Lyell Immunopharma (LYEL) Accumulated Expenses (2020 - 2026) Analysis & Trends
At the end of FY2025, Lyell Immunopharma's Accumulated Expenses came in at $46.52 million, up 14.0% from FY2024.
- Annual Accumulated Expenses shows a five-year compound annual growth rate of 10.7% (FY2020 to FY2025).
- In prior years, Lyell Immunopharma's Accumulated Expenses was $40.82 million in FY2024 (+45.1%), $28.13 million in FY2023 (-2.2%), $28.76 million in FY2022 (-1.0%) and $29.06 million in FY2021 (+3.7%).
- Quarterly Accumulated Expenses has run from a low of $21.4 million in Q2 2022 to a high of $46.52 million in Q4 2025 over five years.
- On a year-over-year basis, Accumulated Expenses has increased in each of the last seven quarters, with growth averaging 15.2% over the last eight quarters.
- The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q4 2024, with growth of 45.1%; the weakest was Q2 2022, with a decline of 16.3%.
- According to Business Quant data, Accumulated Expenses for the three prior quarters was $31.48 million (Q1 2026), $46.52 million (Q4 2025) and $29.31 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Lyell Immunopharma | 220.17 Mn | 220.17 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.99 Mn |
| Mar 31, 2026 | 31.48 Mn |
| Dec 31, 2025 | 46.52 Mn |
| Sep 30, 2025 | 29.31 Mn |
| Jun 30, 2025 | 28.00 Mn |
| Mar 31, 2025 | 31.17 Mn |
| Dec 31, 2024 | 40.82 Mn |
| Sep 30, 2024 | 29.01 Mn |
| Jun 30, 2024 | 25.67 Mn |
| Mar 31, 2024 | 24.91 Mn |
| Dec 31, 2023 | 28.13 Mn |
| Sep 30, 2023 | 29.65 Mn |
| Jun 30, 2023 | 24.83 Mn |
| Mar 31, 2023 | 22.42 Mn |
| Dec 31, 2022 | 28.76 Mn |
| Sep 30, 2022 | 23.57 Mn |
| Jun 30, 2022 | 21.40 Mn |
| Mar 31, 2022 | 22.69 Mn |
| Dec 31, 2021 | 29.06 Mn |
| Sep 30, 2021 | 25.06 Mn |
Lyell Immunopharma Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=LYEL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();